ADVFN - Advanced Financial Network.
HOME» NASDAQ » O » OMCL Stock Price » OMCL Stock News

Omnicell Share News

 Omnicell (mm) Stock Price
OMCL Stock Price
 Omnicell (mm) Stock Chart
OMCL Stock Chart
 Omnicell (mm) Stock News
OMCL Stock News
 Omnicell (mm) Company Information
OMCL Company Information
 Omnicell (mm) Stock Trades
OMCL Stock Trades


Among the companies with shares expected to actively trade in Tuesday's session are Michael Kors Holdings Ltd. (KORS), Juniper Networks Inc. (JNPR) and Seagate Technology Ltd. (STX). Michael Kors' fiscal fourth-quarter earnings more than doubled on broad-based sales increases across its retail, wholesale and licensing segments. The results beat company expectations, and Michael Kors issued guidance that topped Wall Street views, pushing shares to jump 13% in premarket trading to $43.10. Juniper Networks unveiled plans to repurchase up to $1 billion of the company's stock. Shares were up 2.1% to $16.75 premarket. Seagate Technology's shares rose 2.4% to $23.09 premarket after David Einhorn disclosed in a regulatory filing a combined 5.4% stake in the company, riding on gains his funds made from Seagate in the first quarter. Einhorn's Greenlight Capital earlier disclosed a 3.4% stake in the hard-disk drive maker by the end of March. FactSet Research Systems Inc.'s (FDS) fiscal third-quarter earnings rose 11% as the data services provider for the first time passed the $200 million-mark in quarterly revenue. But shares fell 4.4% to $100 premarket as the company gave a somewhat downbeat outlook for fourth-quarter revenue. Shanda Games Ltd.'s (GAME) first-quarter earnings rose 7.6% as the Chinese game developer's revenue continued to grow and as margins strengthened. Shares rose 3.7% to $4.20 premarket as earnings beat analyst expectations. Aegis Capital initiated coverage on Amarin Corp. (AMRN) with a stock-investment rating of buy and a 12-month price target of $25 a share, citing what it calls the "compelling efficacy" for the biotech company's lead drug candidate, a heart drug derived from fish oil. Aegis notes the drug's ability to not only lower high levels of triglycerides but also lower LDL levels, commonly called bad cholesterol, gives it an advantage over current omega-3 fatty acid-derived drug currently on the market for heart issues, Lovaza. Shares of Amarin rose 2.2% to $11.55 premarket. Omnicell Inc. (OMCL) raised its fiscal-year guidance to reflect its May acquisition of MTS Medication Technologies. Shares of the company, which offers supply management and business analytics systems for health care providers, rose 4.4% to $14.40 in light premarket trading. Watchlist: Agrium Inc. (AGU) said it expects its earnings for the first half of the year to be at or near the top-end of its expectations, pointing to strong results across its crop-input business. Online jeweler Blue Nile Inc. (NILE) said it hired Julie Yoakum as its newly titled chief merchandising officer, replacing Senior Vice President Susan Bell, who is retiring this month. BioMed Realty Trust Inc. (BMR) has agreed to acquire Granta Park, a life-science research park in Cambridge, England, for approximately 126.8 million pounds, or $196 million, as the real-estate investment trust continues to grow its portfolio in large research markets. DynaVox Inc. (DVOX) has promoted its operating chief, Michelle Heying, to chief executive officer, effective immediately. Finisar Corp. (FNSR)'s fiscal fourth-quarter earnings fell 20% as the telcommunications-equipment provider was hurt by weaker margins and as weak telecom revenue offset improvement in its data-communications business. Majesco Entertainment Co.'s (COOL) fiscal second-quarter earnings rose 30% as the videogame maker saw its bottom line benefit from fewer charges related to warrants, though revenue and margins declined. The company also lowered its full-year earnings estimates. Sigma Designs Inc. (SIGM) said it has terminated its shareholder-rights plan and decided to separate the roles of chairman and chief executive. Stage Stores Inc.'s (SSI) board approved an 11% increase in the department-store operator's quarterly dividend. Texas Instruments Inc. (TXN) narrowed its second-quarter guidance around its prior midpoint--the first time in about a year the company has done so as business rebounds from its recent lows. United Technologies Corp. (UTX) is offering $1 billion of equity units, as the industrial conglomerate raises funds for its pending $16.5 billion takeover of aerospace-parts maker Goodrich Corp. (GR). -Write to Corrie Driebusch or Nathalie Tadena at [email protected]

Stock News for Omnicell (OMCL)
03/22/201708:30:00Big Data Poses Big Headaches as Health Care Industry Adopts HIT...
03/22/201708:00:00Omnicell's Newest Automated Dispensing Solutions to Be Showcased...
03/22/201704:00:00Omnicell's Newest Automated Dispensing Solutions to Be Showcased...
03/10/201717:29:52Statement of Changes in Beneficial Ownership (4)
03/09/201717:16:34Statement of Changes in Beneficial Ownership (4)
03/09/201717:16:06Statement of Changes in Beneficial Ownership (4)
03/09/201717:15:44Statement of Changes in Beneficial Ownership (4)
03/09/201717:15:44Statement of Changes in Beneficial Ownership (4)
03/09/201717:15:15Statement of Changes in Beneficial Ownership (4)
03/09/201717:14:49Statement of Changes in Beneficial Ownership (4)
03/09/201717:14:49Statement of Changes in Beneficial Ownership (4)
02/21/201718:43:03Statement of Changes in Beneficial Ownership (4)
02/21/201708:00:00Inova Partners with Omnicell to Enhance Pharmacy Supply Chain...
02/15/201716:25:53Current Report Filing (8-k)
02/15/201716:25:31Current Report Filing (8-k)
02/15/201716:01:00Omnicell Reports Results for Fiscal Year and Fourth Quarter 2016
02/14/201708:36:00Omnicell Launches Innovative Medication Adherence Automated Pharmacy...
02/14/201708:00:00Omnicell Launches Innovative Medication Adherence Automated Pharmacy...
02/14/201706:10:32Statement of Ownership (sc 13g)
02/13/201716:26:09Current Report Filing (8-k)

Omnicell and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations